These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 11137068
21. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, Camlin-Shingler K, Secic M. Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431 [Abstract] [Full Text] [Related]
22. Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization-The impact of the boxed warning. Eworuke E, Popat V, Moeny DG. J Clin Pharm Ther; 2017 Aug; 42(4):483-494. PubMed ID: 28543135 [Abstract] [Full Text] [Related]
23. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age. Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y. Contraception; 2011 Mar; 83(3):218-22. PubMed ID: 21310282 [Abstract] [Full Text] [Related]
24. Predictors of higher bone mineral density loss and use of depot medroxyprogesterone acetate. Rahman M, Berenson AB. Obstet Gynecol; 2010 Jan; 115(1):35-40. PubMed ID: 20027031 [Abstract] [Full Text] [Related]
25. Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%. Harel Z, Wolter K, Gold MA, Cromer B, Stager M, Johnson CC, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Burkman R, Nelson A, Marshall S, Bachrach LK. Contraception; 2010 Dec; 82(6):503-12. PubMed ID: 21074012 [Abstract] [Full Text] [Related]
26. An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy. Roden RC, Noritz G, McKnight ER, Bonny AE. Contraception; 2020 Apr; 101(4):273-275. PubMed ID: 31935387 [Abstract] [Full Text] [Related]
27. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception. Cundy T, Cornish J, Roberts H, Reid IR. Am J Obstet Gynecol; 2002 May; 186(5):978-83. PubMed ID: 12015524 [Abstract] [Full Text] [Related]
28. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density. Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L. Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210 [Abstract] [Full Text] [Related]
29. Bone mineral density and DMPA. Westhoff C. J Reprod Med; 2002 Sep; 47(9 Suppl):795-9. PubMed ID: 12380409 [Abstract] [Full Text] [Related]
30. Bone mineral density in women of a low socioeconomic level using DMPA for contraception in rural Upper Egypt. Hussein M, Mahran DG, Farouk OA, El-Assal MA, Fathallah MM, Romih MS. Int J Gynaecol Obstet; 2010 Jul; 110(1):31-4. PubMed ID: 20347086 [Abstract] [Full Text] [Related]
31. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women. Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L. Chin Med J (Engl); 2013 Nov; 126(21):4043-7. PubMed ID: 24229671 [Abstract] [Full Text] [Related]
32. [Status of bone mineral density after the long-standing application of contraception Depo-Provera]. Zeman S, Havlík P, Zemanová J, Němec D. Ceska Gynekol; 2013 Jan; 78(1):116-24. PubMed ID: 23607391 [Abstract] [Full Text] [Related]
33. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Contraception; 2006 Aug; 74(2):90-9. PubMed ID: 16860045 [Abstract] [Full Text] [Related]
34. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Kaunitz AM, Arias R, McClung M. Contraception; 2008 Feb; 77(2):67-76. PubMed ID: 18226668 [Abstract] [Full Text] [Related]
35. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Beksinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F. Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065 [Abstract] [Full Text] [Related]
36. Association between depot medroxyprogesterone acetate (DMPA), physical activity and bone health. Babatunde OO, Forsyth JJ. J Bone Miner Metab; 2014 May; 32(3):305-11. PubMed ID: 23921833 [Abstract] [Full Text] [Related]
37. Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate. Modesto W, Bahamondes MV, Silva dos Santos P, Fernandes A, Dal'Ava N, Bahamondes L. Eur J Contracept Reprod Health Care; 2014 Aug; 19(4):244-9. PubMed ID: 24923792 [Abstract] [Full Text] [Related]
38. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613 [Abstract] [Full Text] [Related]
39. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, Stager M, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Wolter K, Nelson A, Marshall S, Bachrach LK. Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543 [Abstract] [Full Text] [Related]
40. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women. Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K. Contraception; 1997 Sep; 56(3):153-5. PubMed ID: 9347205 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]